IBDEI1FM ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25395,0)
 ;;=V16.42^^147^1591^3
 ;;^UTILITY(U,$J,358.3,25395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25395,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,25395,1,5,0)
 ;;=5^FAM HX, MALIG NEOPL OF PROST
 ;;^UTILITY(U,$J,358.3,25395,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,25396,0)
 ;;=V16.43^^147^1591^4
 ;;^UTILITY(U,$J,358.3,25396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25396,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,25396,1,5,0)
 ;;=5^FAM HX, MALIG NEOPL OF TESTIS
 ;;^UTILITY(U,$J,358.3,25396,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,25397,0)
 ;;=V16.49^^147^1591^5
 ;;^UTILITY(U,$J,358.3,25397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25397,1,4,0)
 ;;=4^V16.49
 ;;^UTILITY(U,$J,358.3,25397,1,5,0)
 ;;=5^FAM HX, OF OTH MALIG NEOPL
 ;;^UTILITY(U,$J,358.3,25397,2)
 ;;=^317954
 ;;^UTILITY(U,$J,358.3,25398,0)
 ;;=V16.51^^147^1591^8
 ;;^UTILITY(U,$J,358.3,25398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25398,1,4,0)
 ;;=4^V16.51
 ;;^UTILITY(U,$J,358.3,25398,1,5,0)
 ;;=5^FAM.HX-MAL. NEOP. KIDNEY
 ;;^UTILITY(U,$J,358.3,25398,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,25399,0)
 ;;=V16.59^^147^1591^9
 ;;^UTILITY(U,$J,358.3,25399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25399,1,4,0)
 ;;=4^V16.59
 ;;^UTILITY(U,$J,358.3,25399,1,5,0)
 ;;=5^FAM.HX-MAL. NEOP. OTH URIN
 ;;^UTILITY(U,$J,358.3,25399,2)
 ;;=^321503
 ;;^UTILITY(U,$J,358.3,25400,0)
 ;;=V16.6^^147^1591^12
 ;;^UTILITY(U,$J,358.3,25400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25400,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,25400,1,5,0)
 ;;=5^FAMILY HX-LEUKEMIA
 ;;^UTILITY(U,$J,358.3,25400,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,25401,0)
 ;;=V16.7^^147^1591^7
 ;;^UTILITY(U,$J,358.3,25401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25401,1,4,0)
 ;;=4^V16.7
 ;;^UTILITY(U,$J,358.3,25401,1,5,0)
 ;;=5^FAM HX-LYMPH NEOPLAS NEC
 ;;^UTILITY(U,$J,358.3,25401,2)
 ;;=^295299
 ;;^UTILITY(U,$J,358.3,25402,0)
 ;;=V16.8^^147^1591^13
 ;;^UTILITY(U,$J,358.3,25402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25402,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,25402,1,5,0)
 ;;=5^FAMILY HX-MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,25402,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,25403,0)
 ;;=V17.89^^147^1592^1
 ;;^UTILITY(U,$J,358.3,25403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25403,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,25403,1,5,0)
 ;;=5^FAM HX MUSCULOSK DIS NEC
 ;;^UTILITY(U,$J,358.3,25403,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,25404,0)
 ;;=V17.49^^147^1592^2
 ;;^UTILITY(U,$J,358.3,25404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25404,1,4,0)
 ;;=4^V17.49
 ;;^UTILITY(U,$J,358.3,25404,1,5,0)
 ;;=5^FAM HX-CARDIOVAS DIS NEC
 ;;^UTILITY(U,$J,358.3,25404,2)
 ;;=^295306
 ;;^UTILITY(U,$J,358.3,25405,0)
 ;;=V17.6^^147^1592^3
 ;;^UTILITY(U,$J,358.3,25405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25405,1,4,0)
 ;;=4^V17.6
 ;;^UTILITY(U,$J,358.3,25405,1,5,0)
 ;;=5^FAM HX-CHR RESP COND NEC
 ;;^UTILITY(U,$J,358.3,25405,2)
 ;;=^295308
 ;;^UTILITY(U,$J,358.3,25406,0)
 ;;=V17.3^^147^1592^4
 ;;^UTILITY(U,$J,358.3,25406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25406,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,25406,1,5,0)
 ;;=5^FAM HX-ISCHEM HEART DIS
 ;;^UTILITY(U,$J,358.3,25406,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,25407,0)
 ;;=V17.2^^147^1592^5
 ;;^UTILITY(U,$J,358.3,25407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25407,1,4,0)
 ;;=4^V17.2
 ;;^UTILITY(U,$J,358.3,25407,1,5,0)
 ;;=5^FAM HX-NEUROLOG DIS NEC
 ;;^UTILITY(U,$J,358.3,25407,2)
 ;;=^295304
 ;;^UTILITY(U,$J,358.3,25408,0)
 ;;=V17.0^^147^1592^6
 ;;^UTILITY(U,$J,358.3,25408,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1FM
